Document is current
Any future updates will be listed below
-
Authors
Pallarès, N
Inouzhe, H
Straw, S
Safdar, N
Fernández, D
Cortés, J
Rodríguez, L
Videla, S
Barrio, I
Witte, KK
Carratalà, J
Tebé, C
,
Abelenda-Alonso, Gabriela
Rombauts, Alexander
Oriol, Isabel
Simonetti, Antonella F.
Rodríguez-Molinero, Alejandro
Izquierdo, Elisenda
Díaz-Brito, Vicens
Gudiol, Carlota
Aranda-Lobo, Judit
Arroyo, Marta
Pérez-López, Carlos
Sanmartí, Montserrat
Moreno, Encarna
Alvarez, Maria C.
Faura, Ana
González, Martha
Cruz, Paula
Colom, Mireia
Perez, Andrea
Serrano, Laura
,
Besalú, Mireia
Cobo, Erik
Garmendia, Leire
Gómez, Guadalupe
Hereu, Pilar
Langohr, Klaus
Molist, Gemma
Pérez-Álvarez, Núria
Piulachs, Xavier
-
Funding
Funding for this research was provided by:
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya (2020PANDE00148)
Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 01421 (GRBIO))
Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 01421 (GRBIO))
Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 01421 (GRBIO))
Departament de Recerca i Universitats de la Generalitat de Catalunya (2021 SGR 01421 (GRBIO))
Ministerio de Ciencia e Innovación (PID2019-104830RB-I00/ DOI (AEI): 10.13039/501100011033)
Ministerio de Ciencia e Innovación (PID2019-104830RB-I00/ DOI (AEI): 10.13039/501100011033)
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 17 June 2024
First Online: 16 July 2024
Declarations
:
: Regarding the MetroSud cohort, the study was approved by the Bellvitge Hospital Research Ethics Committee with medicines (CREm) in accordance with Spanish legislation and was performed in accordance with the Helsinki Declaration of 1964. The need for patient informed consent was waived by the ethics committee. Bellvitge's CREm decision was the basis for the approval of the remaining hospital centres.Regarding the Leeds Teaching Hospitals cohort, approval was given following institutional governance review following submission to the Clinical Audit Database at Leeds Teaching Hospitals NHS Trust. In view of the retrospective nature, individual patient consent was waived as appropriate data protection safeguards were in place.
: Not applicable.
: CT has received fees for speaker lectures and talks from Amgen, Boehringer Ingelheim, and Gedeon Richter, outside the submitted work.The rest of authors declare that they have no competing interests.
